GlassScriptPhysician profile
Sushrut Dharmadhikari
NPI 1831496942
$3,606.31
in general payments reported to CMS, 2019-2025
14 companies · $46.83 in 2025
The $46.83 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2020: $72.19 · 2021: $408 · 2022: $603 · 2023: $939 · 2024: $201 · 2025: $46.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,089.35 | 2021-2023 | Solitaire X, Pipeline, Reacttm |
| Microvention, INC. | $1,019.42 | 2019 | |
| Depuy Synthes Sales INC. | $291.49 | 2019-2024 | Embotrap |
| Imperative Care, INC | $273.88 | 2023-2024 | Zoom 88-T Large Distal Platform, Tracstar Large Distal Platform |
| Astrazeneca Pharmaceuticals LP | $192.61 | 2021-2022 | |
| Stryker Corporation | $174.21 | 2019-2025 | Target, Universal Neuro 3 |
| Medtronic USA, INC. | $160.66 | 2019 | |
| Balt USA, LLC | $142.49 | 2022-2024 | Optima Coil System |
| Penumbra, INC. | $134.04 | 2023 | Red 72 |
| Qapel Medical INC | $54.82 | 2023 | |
| Arbor Pharmaceuticals, INC. | $24.16 | 2022 | |
| Portola Pharmaceuticals, LLC | $17.48 | 2020 | |
| Boston Scientific Corporation | $16.19 | 2022 | |
| Amgen INC. | $15.51 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushrut Dharmadhikari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.